NCT02230540

Brief Summary

The aim of this investigation is to study how the position of different catheters affect drainage of the bladder.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2014

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2014

Completed
4 days until next milestone

Study Start

First participant enrolled

September 1, 2014

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 3, 2014

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

February 15, 2016

Completed
Last Updated

March 15, 2016

Status Verified

February 1, 2016

Enrollment Period

Same day

First QC Date

August 28, 2014

Results QC Date

January 18, 2016

Last Update Submit

February 17, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Residual Volume Less Than 100ml

    The primary endpoint was "Residual volume less than 100 ml (Yes/No)" assessed after catheterization when placed at fixed heights (25, 20, 15, 10 and 0 cm) over the wheelchair seat. Prior to the catheterization corresponding to height 25 cm, a solution was instilled into the bladder to ensure a volume equal to 300 ml. The residual volume at height 25 cm was then calculated as 300 ml minus the volume emptied during catheterization. The residual volume corresponding to height 20 cm was calculated as the residual volume corresponding to height 25 minus the additional volume emptied at height 20. The residual volume corresponding to height 15, 10 and 0 cm were derived similarly. Calculated residual volumes were negative, likely due to faulty ultrasound scans performed on subjects in sitting position. Consequently, the changes in bladder volumes, re-worded from "300ml - collected volume \<100ml" to "collected volume \> 200ml", were used to interpret the primary endpoint.

    2-4 hours

Study Arms (2)

Sequence A

EXPERIMENTAL

Catheterization with SelfCath (comparator) followed by measurement of residual urine. Then catheterization with Product A in different positions. Measurement of residual urine at different positions.

Device: SelfCath (comparator)Device: Product A SelfCath and urine bag, Conveen Security+

Sequence B

EXPERIMENTAL

Based on results from sequence A, sequence B may or may not be initiated. Catheterization with SelfCath (comparator) followed by measurement of residual urine. Then catheterization with Product B in different positions. Measurement of residual urine at different positions.

Device: SelfCath (comparator)Device: Product B SelfCath and urine bag, Conveen Contour

Interventions

Commercially available CE-marked catheter for urinary drainage.

Sequence ASequence B

SelfCath and urine bag, Conveen Security+ (both commercially available CE-marked devices).

Sequence A

SelfCath and urine bag, Conveen Contour (both commercially available CE-marked devices).

Sequence B

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Has given written informed consent
  • Is at least 18 years of age and has full legal capacity
  • Is a male
  • Has an Spinal Cord Injury diagnosis

You may not qualify if:

  • Participating in other interventional clinical investigations or have previously participated in this investigation
  • Known hypersensitivity toward any of the test products
  • Serious abdominal scars
  • Symptoms of urinary tract infections

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Per Bagi

Copenhagen, 2100, Denmark

Location

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Results Point of Contact

Title
Per Bagi, MD
Organization
Rigshospitalet, Department of Urology

Study Officials

  • Per Bagi, MD

    Rigshospitalet, Denmark

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 28, 2014

First Posted

September 3, 2014

Study Start

September 1, 2014

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

March 15, 2016

Results First Posted

February 15, 2016

Record last verified: 2016-02

Locations